Corgentech, Inc.

42 articles about Corgentech, Inc.

• Corgentech, Inc. Changes Name To Anesiva To Reflect Focus On Robust Pipeline Of Pain Therapeutics

  6/22/2006

• Corgentech, Inc. Secures $30 Million Committed Equity Financing Facility

  6/20/2006

• Corgentech, Inc. Pain Drug, 4975, Demonstrates Statistically Significant Pain Reduction After Knee Replacement Surgeries; Shares Up

  6/14/2006

• Corgentech, Inc. To Present At Pacific Growth Equities Life Sciences Growth Conference And Needham & Company Fifth Annual Biotechnology And Medical Technology Conference

  6/7/2006

• Corgentech, Inc. Announces Appointment Of K. Peony Yu As Vice President, Clinical Research And Michael Leong As Director, Clinical Research

  6/6/2006

• Corgentech, Inc. Announces Appointment Of Susan Kramer As Vice President Of Preclinical Development

  5/30/2006

• Corgentech, Inc. To Host Webcast Conference Call On Wednesday, May 24, 2006

  5/22/2006

• Corgentech, Inc. Announces Scientific Presentation Of Pivotal Phase 3 Data Demonstrating Significant Pain Reduction Associated With Fast-Acting, Needlefree Local Anesthetic In Children

  5/18/2006

• Corgentech, Inc. Announces First Quarter 2006 Financial Results

  5/5/2006

• Corgentech, Inc. Presents Additional Phase 2 Data Demonstrating 4975 Provides Early, Sustained Relief Of Pain And Improved Function In Elbow Tendonitis

  5/4/2006

• Corgentech, Inc. Announces Presentation Of 3268 Phase 3 Data At 2006 Pediatric Academic Societies' Annual Meeting

  4/28/2006

• Corgentech, Inc. To Announce First Quarter 2006 Financial Results And Host Webcast Conference Call On May 4, 2006

  4/27/2006

• Corgentech, Inc. Files $100 Million Mixed Shelf Offering

  4/18/2006

• The Day In Review: Sanofi-Aventis (France) Adds To Generics Business

  3/26/2006

• Corgentech, Inc. To Present At CIBC World Markets' Annual Biotechnology And Specialty Pharmaceuticals Conference 2006

  3/26/2006

• Corgentech, Inc. Says Pain Drug, 4975 For Hernia Repair Pain Fails In Mid-Stage Study

  3/26/2006

• The Day In Review: Vertex Pharmaceuticals Incorporated Reports Positive Arthritis Drug News

  3/9/2006

• Corgentech, Inc. Phase 2 Trial Of ALGRX 4975 Meets Primary Endpoint Of Decreased Pain For Tendonitis Patients

  3/9/2006

• Corgentech, Inc. Presents Clinical Data From Phase 1/2 Trial Of Avrina(TM), Drug Candidate For Eczema

  3/6/2006

• Corgentech, Inc. To Webcast Presentation From Lehman Brothers 2006 Global Healthcare Conference

  3/3/2006